Abstract
The renal transplant recipients (RTR) have a significantly increased risk of developing a wide variety of cutaneous neoplasms. Among these the nonmelanoma skin cancer (NMSC) represents the most common form. This is related to the effects of Immunosuppressive drugs used in post-transplant anti-rejection therapy. Another factor is sleep restriction, which changes the normal physiology of th…